Press release Communiqué de presse

Share the news     Partagez les nouvelles

Email Facebook LinkedIn Twitter

Press release Communiqué de presse

March 20, 2006 20 March, 2006

Pheromone Issues Stock Options

Kelowna, B.C. - Pheromone Sciences Corp. ("Pheromone") is pleased to announce that it has granted to certain directors, officers and employees of the Company incentive stock options to purchase up to a total of 2,800,000 common shares at a price of $0.40 per share in accordance with the policies of the TSX Venture Exchange.

Pheromone Sciences Corp. is a biotechnology and medical diagnostics device research and development company that focuses on commercializing medical technologies.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.


"Dev Randhawa"

Dev Randhawa, President

For further information contact:

TEL: (250) 868-8177 FAX: (250) 868-8493

Mr. Phil Morehouse Pheromone Sciences Corp.